AI MARKET SCANNING

PTC Therapeutics, Inc.

AVG HISTORICAL GAP -1.39%
MAX GAP RECORD -19.16%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $PTCT
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Oct 29, 2026 Earnings Release 2026-10-29 (AFTER CLOSE (16:00))
+0.45%
Jul 30, 2026 Earnings Release 2026-07-30 (AFTER CLOSE)
-6.09%
May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE)
+14.86%
Feb 19, 2026 Earnings Release 2026-02-19 (AFTER CLOSE)
-2.07%
Nov 04, 2025 Earnings Release 2025-11-04 (AFTER CLOSE)
+3.37%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
-10.64%
May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE)
+8.87%
Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE)
-10.12%

VOLATILITY & GAP BIAS

AVG GAP MOVE 6.8%
Bullish Gaps (7)
Bearish Gaps (8)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $PTCT

EXECUTIONS2 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-19 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 4424m +6.00%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company provides Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC)…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗